George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksHargreaves Lansdown Regulatory News (HL.)

Share Price Information for Hargreaves Lansdown (HL.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 754.60
Ask: 755.40
Change: 18.80 (2.55%)
Spread: 0.80 (0.106%)
Open: 753.80
High: 762.00
Low: 743.20
Prev. Close: 736.20
HL. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

8 Dec 2022 08:00

RNS Number : 0511J
Hargreaves Lansdown PLC
08 December 2022
 

08 December 2022

 

Hargreaves Lansdown plc ("HL" or the "Company")

 

CEO succession

 

 

The Board is pleased to announce the appointment of Dan Olley as Chief Executive Officer and Executive Director of the Company once released from current obligations in 2023, and subject to regulatory approval. 

 

Dan will succeed Chris Hill, who announced on 17 October 2022 his intention to retire after six years in the role. Until Dan joins, and as previously announced, Chris will remain in place as Chief Executive Officer and thereafter will support HL until November 2023 to provide continuity and ensure an orderly transition.

 

Dan is a globally renowned technology leader, having delivered transformational change and growth, including scaling platform businesses internationally. He brings cutting-edge strategic, digital and operational expertise and is uniquely placed to lead the ongoing execution of HL's strategy, given his non-executive director role on the Board since June 2019. 

Dan will step down from his current role as CEO at dunnhumby, a global customer data science company, where he has been leading the development and implementation of a digital-first, data-driven transformation. Prior to dunnhumby, Dan spent seventeen years at RELX where he held a series of senior digital roles and helped drive RELX's digital transformation into the world-leading global information analytics company it is today.

 

Deanna Oppenheimer, HL Chair, said: "Having worked with Dan in a non-executive capacity over the last three years, I have been highly impressed by both his strategic insight and his depth of experience in digital transformation and, as such, I am delighted that he will be the next CEO of HL. His strong transformation leadership across complex scale businesses and experience of driving growth and client engagement through digital change is a great match for HL as we continue to deliver on our strategy. We very much look forward to working together with Dan in this new capacity when he joins us next year."

 

Dan Olley said: "I am delighted to be joining HL as its next CEO. This is a company with an exceptional track record, a strong strategic position and a formidable brand. I am tremendously excited at the opportunity to lead the business through its digital transformation and into its next stage of growth. Having joined the Board in 2019, I have a deep understanding and passion for the business. HL has a clear purpose, highly talented people and an obsession for client service. I look forward to building on the work of Chris and the team to drive even more value for our clients and to capitalise on the opportunities ahead."

 

There is no additional information required to be disclosed under Listing Rule 9.6.13.

 

Enquiries:

Hargreaves Lansdown plc

James Found +(0) 7970 066 634

Danny Cox +(0) 7989 672 071

Nick Cosgrove/ Caroline Daniel, Brunswick Group +(0) 207 404 5959

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZMGZNRKGZZG
Date   Source Headline
25th Apr 20242:43 pmRNSDirector Declaration
19th Apr 20241:56 pmRNSDirector/PDMR Shareholding
4th Apr 202411:24 amRNSDirector/PDMR Shareholding
7th Mar 20241:54 pmRNSDirector/PDMR Shareholding
28th Feb 20244:01 pmRNSDirector/PDMR Shareholding
27th Feb 20242:29 pmRNSDirector/PDMR Shareholding
26th Feb 20244:43 pmRNSDirector/PDMR Shareholding
23rd Feb 20244:05 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSHalf-year Report
9th Feb 202412:10 pmRNSNotice of Results
6th Feb 202412:08 pmRNSDirectorate Change
1st Feb 20247:09 amRNSDirector Declaration
17th Jan 202412:03 pmRNSDirector Declaration
2nd Jan 202410:06 amRNSDirector Declaration
20th Dec 202312:50 pmRNSDirector/PDMR Shareholding
14th Dec 202312:06 pmRNSDirector Declaration
11th Dec 20237:17 amRNSDirector Declaration
8th Dec 20234:33 pmRNSResult of AGM
6th Dec 20238:10 amRNSDirector Declaration
29th Nov 20237:00 amRNSDirectorate Change
7th Nov 20231:54 pmRNSNotice of AGM
23rd Oct 20238:00 amRNSAnnual Financial Report
19th Oct 20237:00 amRNSTrading Statement
12th Oct 20234:10 pmRNSDirector/PDMR Shareholding
12th Oct 20234:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:21 pmRNSDirector/PDMR Shareholding
21st Sep 20234:15 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
1st Sep 20239:59 amRNSNotice of Results
19th Jul 20237:00 amRNSTrading Statement
17th Jul 20234:32 pmRNSDirectorate Change
10th Jul 202311:00 amRNSDirectorate Change
15th Jun 202312:13 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirectorate Change
15th May 20234:51 pmRNSDirector/PDMR Shareholding
10th May 20234:01 pmRNSDirector/PDMR Shareholding
4th May 202311:00 amRNSDirector Declaration
4th May 20237:00 amRNSTrading Statement
25th Apr 20232:13 pmRNSDirector/PDMR Shareholding
1st Mar 202310:22 amRNSDirector/PDMR Shareholding
15th Feb 20237:00 amRNSHalf-year Report
27th Jan 202312:02 pmRNSDirector Declaration
23rd Jan 202310:10 amRNSNotice of Results
19th Jan 20233:33 pmRNSHolding(s) in Company
20th Dec 20222:01 pmRNSDirector/PDMR Shareholding
16th Dec 202211:05 amRNSDirector Declaration
8th Dec 20228:00 amRNSDirectorate Change
24th Oct 20223:00 pmRNSHolding(s) in Company
19th Oct 20225:16 pmRNSResult of AGM
17th Oct 20227:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.